gip/glp 1-agonist tirzepatide Pharmacogenomics of Tirzepatide: Genomic Insights into Dual GIP/GLP-1 Agonist Response in Type 2 Diabetes and Atherosclerosis GLP-1/GIP dual agonist tirzepatide normalizes

Your healthcare provider should check your blood pressure and heart rate before you start taking, and while you take CONTRAVE

While additional research is needed to determine how Zepbound might be connected to eye floaters but it may be linked to poorly controlled diabetes which can lead to diabetic retinopathy, rapid or inadequate blood sugar regulation by the medication, episodes of low blood sugar (hypoglycemia), an inflammatory reaction, or interactions with other drugs

GLP-1 Side Effects Most people tolerate GLP-1 medications reasonably well overall

However, some patterns stood out

Clin Endocrinol (Oxf)

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial